First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Common Equity (2024 - 2026)

Updated

Analysis

First Tracks Biotherapeutics (TRAX) Common Equity (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 81.53 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -4.58 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 51.81 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 13.04 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 89.30 Bn
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - 151.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 151.01 Mn
Jun 30, 2026 168.80 Mn
Mar 31, 2026 257.46 Mn
Dec 31, 2025 287.49 Mn
Sep 30, 2025 231.64 Mn
Jun 30, 2025 270.66 Mn
Mar 31, 2025 357.72 Mn
Dec 31, 2024 391.60 Mn
API Access

First Tracks Biotherapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=TRAX&period=max&api_key=YOUR_API_KEY